Skip to main content

The dopamine hypothesis revisited

  • Chapter
The Biological Basis of Schizophrenia

Abstract

A generation ago, it would have been unthinkable to attempt to define schizophrenia in terms of anything other than the somewhat mysterious psychological concepts of the time. This approach, which had little contact with everyday physical experience, produced theoretical constructs that were blinkered by their own limited set of assumptions. The major questions were pre-empted, the arguments circular and, scientifically, no progress was possible.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abrams, S. R. and Taylor, M. A. (1976). Manic and schizoaffective disorder, manic type: a comparison. Am. J. Psychiatry, 33, 579

    CAS  Google Scholar 

  • Angrist, B., Thompson, H., Shopsin., B. and Gershon, S. (1975). Clinical studies with dopamine-receptor stimulants. Psychopharmacologia, 44, 273

    Article  PubMed  CAS  Google Scholar 

  • Baldessarini, R. J. (1975). In Handbook of Neuropsychopharmacology, (L. Iversen, S. Iversen and S. Snyder, eds.) p. 37 (New York: Plenum)

    Google Scholar 

  • Bloom, F., Segal, D. and Guillemin, R. (1976). Endorphins: Profound behavioral effects in rats suggest new etiological factors in mental illness. Science, 194, 630

    Article  PubMed  CAS  Google Scholar 

  • Bradbury, A. F., Smyth, D. G., Snell, C. R., Birdsall, M. and Hulme, E. C. (1976). C fragment of lipoprotein has a high affinity for brain opiate receptors. Nature (London), 260, 793

    Article  CAS  Google Scholar 

  • Buchsbaum, M. S., Cousey, R. D. and Murphy, D. L. (1976). The biochemical high-risk paradigm: Behavioral and familial correlates of low platelet monoamine oxidase activity. Science, 194, 339

    Article  PubMed  CAS  Google Scholar 

  • Burt, D. R., Enna, S., Creese, I. and Snyder, S. H. (1975). Dopamine receptor binding in the corpus striatum of mammalian brain. Proc. Nat. Acad. Sci. US, 72, 4655

    Article  CAS  Google Scholar 

  • Clay, G. A. and Brougham, L. R. (1975). Haloperidol binding to an opiate receptor. Biochem. Pharmac., 24, 1363

    Article  CAS  Google Scholar 

  • Connell, P. H. (1958). Amphetamine Psychosis. (London: Chapman and Hall)

    Google Scholar 

  • Cools, A. R. and van Rossum, J. M. (1976). Excitation-mediating and inhibition-mediating dopamine receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. Psychopharmacologia, 45, 243

    Article  PubMed  CAS  Google Scholar 

  • Creese, I., Burt, D. R. and Snyder, S. H. (1975). Dopamine receptor bindings: differentiation of agonist and antagonist states with 3H dopamine and 3H haloperidol. Life Sci., II, 17, 993

    Article  CAS  Google Scholar 

  • Creese, I., Feinberg, A. P. and Snyder, S. H. (1976a). Butyrophenone influences on the opiate receptor. Eur. J. Pharmac, 36, 231

    Article  CAS  Google Scholar 

  • Creese, I., Burt, D. R. and Snyder, S. H. (1976b). Dopamine receptor binding predicts clinical and pharmacological potencies of anti-schizophrenic drugs. Science, 192, 481

    Article  PubMed  CAS  Google Scholar 

  • De Jong, H. (1945). Experimental Catatonia. (Baltimore: Williams and Wilkins)

    Google Scholar 

  • Dohan, F. C., Grasberger, J. C., Lowell, F. M., Johnston, H. I. Jr. and Arbergast, A. (1969). Relapsed schizophrenics: more rapid improvement on a milk and cereal-free diet. Br. J. Psychiatry., 115, 595

    Article  PubMed  CAS  Google Scholar 

  • Feldberg, W. (1976). Psychol. Med., 6, 359

    Article  PubMed  CAS  Google Scholar 

  • Glover, V., Sandler, M., Owen, F. and Riley, G. J. (1977). Dopamine is a monoamine oxidase B substrate in man. Nature (London), 265, 80

    Article  CAS  Google Scholar 

  • Goodwin, B. L., Ruthven, C. R. J. and Sandler, M. (in preparation).

    Google Scholar 

  • Henning, M. (1973). In Frontiers in Catecholamine Research, (E. Usdin and S. Snyder, eds.) p. 595 (New York: Pergamon)

    Google Scholar 

  • Hughes, J. (1975). Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res., 88, 295

    Article  PubMed  CAS  Google Scholar 

  • Inanaga, K., Nakazawa, Y., Inoue, K., Tachibana, H., Oshima, M., Kotorii, T., Tanaka, M. and Ogawa, N. (1975). Double blind controlled study of L-dopa therapy in schizophrenia. Fol. Psychiatr. Neurol. (Jpn.), 29, 123

    CAS  Google Scholar 

  • Jacquet, Y. F. and Marks, N. (1976). The C-fragment of-lipoprotein: an endogenous neuroleptic or antipsychotogen? Science, 194, 632

    Article  PubMed  CAS  Google Scholar 

  • Janowsky, D. S., El-Yousef, M. K. and Davis, J. M. (1972). The elicitation of psychiatric symptomology by methylphenidate. Compr. Psychiatry., 13, 83

    Article  Google Scholar 

  • Kebabian, J. W., Petzold, G. I. and Greengard, P. (1972). Proc. Nat. Acad. Sci. USA, 69, 2145

    Article  PubMed  CAS  Google Scholar 

  • Mantegazza, P. and Riva, M. J. (1963). Amphetamine-like activity of β1-phenylethylamine after a monoamine oxidase inhibitor in vivo. J. Pharm. Pharmac., 15, 472

    Article  CAS  Google Scholar 

  • Miller, R.J., Horn, A. S. and Iversen, L. L. (1974). The action of neuroleptic drugs on dopamine-stimulated adenosine—3′5′-monophosphate production in the rat neostriatum and limbic forebrain. Mol. Pharmac., 10, 759

    CAS  Google Scholar 

  • Murphy, D. L. and Donnelly, C. H. (1974). In: Neuro-psychopharmacology of Monoamines and their Regulatory Enzymes, (E. Usdin, ed.) p. 71 (New York: Raven)

    Google Scholar 

  • Owen, F., Bourne, R., Crow, T. J., Johnstone, E. C., Bailey, A. R. and Hershon, H. I. (1976). Arch. Gen. Psychiat., 33, 1370

    Article  PubMed  CAS  Google Scholar 

  • Randrup, A. and Munkvad, I. (1968). Behavioural stereotypes induced by pharmacological agents. Pharmakopsychiat. Neuro-Psychopharmak., 1, 18

    Google Scholar 

  • Rotrosen, J., Angrist, B. M., Gershon, S., Sachar, E. J. and Halpern, F. S. (1976). Psychopharmacology, 51, 1

    Article  PubMed  CAS  Google Scholar 

  • Sandler, M. and Reynolds, G. P. (1976). Does phenylethylamine cause schizophrenia? Lancet, i, 70

    Article  Google Scholar 

  • Sandler, M., Goodwin, B. L., Ruthven, C. R. J. and Coppen, A. (In preparation, a)

    Google Scholar 

  • Sandler, M., Goodwin, B. L., Ruthven, C. R. J. and Kumar, P. (In preparation, b)

    Google Scholar 

  • Schildkraut, J. J., Herzog, J. M., Orsulak, P. J., Edelman, S. E., Shein, H. M. and Frazier, S. H. (1976). Reduced platelet monoamine oxidase activity in a sub-group of schizophrenic patients. Am. J. Psychiatry, 133, 438

    PubMed  CAS  Google Scholar 

  • Schwartz, M. A., Aikens, A. M. and Wyatt, R. J. (1974). Monoamine oxidase activity in brains from schizophrenic and mentally normal individuals. Psychopharmacologia, 38, 319

    Article  PubMed  CAS  Google Scholar 

  • Singh, M. M. and Kay, S. R. (1976). Wheat gluten as a pathogenic factor in schizophrenia. Science, 191, 401

    Article  PubMed  CAS  Google Scholar 

  • Snyder, S. H., Banerjee, S. P., Yamamura, H. I. and Greenberg, D. (1974). Drugs, neurotransmitters and schizophrenia. Science, 184, 1234

    Article  Google Scholar 

  • Snyder, S. H. (1975). Opiate receptor in normal and drug altered brain function. Nature (London), 257, 185

    Article  CAS  Google Scholar 

  • Stille, G. (1971). Zur Pharmakologie katatonigener Stoffe. (Aulendorf: Cantor)

    Google Scholar 

  • Strian, F., Micheler, E. and Benkert, O. (1972). Pharmakopsychiat. Neuro-Psychopharmak., 5, 198

    Google Scholar 

  • Taychenne, P. F., Calne, D. B., Leigh, P. N., Greenacre, J. K., Reid, J. L., Petrie, A. and Bamji, A. N. (1975). Idiopathic Parkinsonism treated with bromocriptine. Lancet, ii, 473

    Google Scholar 

  • Ungerstedt, U. (1968). 6-Hydroxydopamine induced degeneration of central monoamine neurones. Eur. J. Pharmac., 5, 107

    Article  CAS  Google Scholar 

  • Waldmeier, P. C., Delini-Stula, A. and Maître, L. (1976). Preferential deamination of dopamine by an A type monoamine oxidase in rat brain. Naunyn-Schmiedeberg’s Arch. Pharmac, 292, 9

    Article  CAS  Google Scholar 

  • Whaley, M. and Govindachar, T. R. (1951). In Organic Reactions, (R. Adams (ed.) vol. 6, p. 151, (New York: Wiley)

    Google Scholar 

  • Yang, H. Y.-T. and Neff, N. H. (1973). Beta phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J. Pharmac. Exp. Ther., 187, 365

    CAS  Google Scholar 

  • Yaryura-Tobias, J. A., Diamond, B. and Merlis, S. (1970). The action of L-dopa on schizophrenic patients. Curr. Ther. Res., 12, 528

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1978 MTP Press Limited

About this chapter

Cite this chapter

Sandler, M. (1978). The dopamine hypothesis revisited. In: Hemmings, G., Hemmings, W.A. (eds) The Biological Basis of Schizophrenia. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6206-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-6206-7_7

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-6208-1

  • Online ISBN: 978-94-011-6206-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics